ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $24 | -75.8% | 14,994 | -6.1% | 0.00% | -100.0% |
Q4 2022 | $99 | -100.0% | 15,969 | -80.7% | 0.00% | -85.7% |
Q3 2022 | $555,000 | +41.6% | 82,889 | +34.6% | 0.01% | +75.0% |
Q2 2022 | $392,000 | -29.1% | 61,583 | -44.3% | 0.00% | +33.3% |
Q4 2021 | $553,000 | -54.8% | 110,514 | +8.8% | 0.00% | -50.0% |
Q3 2021 | $1,224,000 | +317.7% | 101,580 | +633.7% | 0.01% | +500.0% |
Q2 2021 | $293,000 | -35.7% | 13,844 | -14.9% | 0.00% | -50.0% |
Q1 2021 | $456,000 | +12.9% | 16,266 | +4.6% | 0.00% | 0.0% |
Q4 2020 | $404,000 | -54.4% | 15,549 | -34.7% | 0.00% | -66.7% |
Q3 2020 | $885,000 | +218.3% | 23,819 | +340.0% | 0.01% | +200.0% |
Q2 2020 | $278,000 | -68.1% | 5,414 | -80.4% | 0.00% | -75.0% |
Q1 2020 | $872,000 | -28.9% | 27,652 | +34.5% | 0.01% | -27.3% |
Q4 2019 | $1,226,000 | +105.7% | 20,563 | +38.6% | 0.01% | +120.0% |
Q1 2019 | $596,000 | +193.6% | 14,840 | +236.9% | 0.01% | +150.0% |
Q4 2018 | $203,000 | -81.0% | 4,405 | -83.9% | 0.00% | -80.0% |
Q2 2018 | $1,071,000 | -83.7% | 27,319 | -70.0% | 0.01% | -81.1% |
Q1 2018 | $6,580,000 | +3206.5% | 90,973 | +2909.4% | 0.05% | +2550.0% |
Q4 2017 | $199,000 | +15.7% | 3,023 | -11.7% | 0.00% | 0.0% |
Q3 2017 | $172,000 | -46.9% | 3,423 | -51.2% | 0.00% | -33.3% |
Q2 2017 | $324,000 | +128.2% | 7,008 | +74.5% | 0.00% | +200.0% |
Q1 2017 | $142,000 | +40.6% | 4,017 | -50.2% | 0.00% | 0.0% |
Q4 2016 | $101,000 | -72.5% | 8,062 | +79.7% | 0.00% | -50.0% |
Q2 2015 | $367,000 | – | 4,487 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |